Varicella Zoster Virus Latency in Human Ganglia
Varicella Zoster Virus Latency in Human Ganglia
批准号:
7425976
负责人:
RANDALL J. COHRS
金额:
$38.38万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
21pAdolescenceAdultAffinityAutonomic ganglionBrainChickenpoxChildhoodChronic intense painCloningCranial NervesCranial nerve palsiesCultured CellsDNA BindingDNA SequenceDatabasesDepthDetectionElderlyEpitopesExanthemaFacility Construction Funding CategoryFluorescenceFundingGalactosidaseGangliaGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomeGoalsHerpes zoster diseaseHerpesvirus Type 3HistidineHumanHybridsImmunocompromised HostImmunohistochemistryIn SituIn VitroIndividualInfectionIntercistronic RegionLaboratoriesLatent VirusLeadLibrariesLocalizedLocationLytic PhaseMapsMessenger RNAModelingMorbidity - disease rateMotorMyelitisMyxoid cystNeuronsNumbersOpen Reading FramesParesisPolymerase Chain ReactionPopulationPostherpetic neuralgiaProtein Interaction MappingProtein-Protein Interaction MapProteinsRangeRecombinant AntibodyRecombinantsRelative (related person)ReportingResearchReverse Transcriptase Polymerase Chain ReactionSerologicalSystemTechnologyTestingTimeTransactivationTranscriptTranscriptional ActivationViralViral ProteinsVirusVirus LatencyYeastsZoster Sine Herpetebasechronic painexpression vectorlatent infectionmortalitynervous system disorderneurotropicpathogenprotein functionresearch studyspinal nerve posterior roottherapy designvaricella-zoster virus immediate early protein 62vectorviral DNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Varicella zoster virus (VZV) is an ubiquitous human pathogen. Primary infection causes childhood chickenpox, leading to latency in cranial nerve, dorsal root and autonomic ganglia. VZV reactivation, frequent in the elderly and immunocompromised population, results in significant neurological disease. Zoster and postherpetic neuralgia predominate, but many humans develop myelitis, segmental motor weakness, cranial nerve palsies, and a severe, often
fatal vasculopathy in the brain. We have also shown that VZV reactivation can produce chronic intense pain in the absence of rash. Although the mechanism controlling VZV latency is not understood, it is likely to depend upon virus gene transcription, thus providing the rationale for our hypothesis that VZV gene expression in human ganglia during latency functions to maintain latent infection. Identification of the VZV genes expressed during latency is critical to understanding latent infection. Until the advent of high throughput array-based technology, such analyses were not feasible, and <20% of the VZV genome has been analyzed for latent virus transcripts. Further, merely identifying the latently transcribed VZV genes is insufficient. Since control of VZV latency is likely to involve virus proteins, characterization of latently expressed viral proteins is also critical to understanding virus gene regulation. Thus, our long-term goal is the detailed characterization, including functional analysis, of VZV genes expressed
in latently infected human ganglia. Our specific aims will: (1) identify latently transcribed VZV genes by transcriptional array analysis, confirm the authenticity of the transcripts by sequencing, and determine the abundance of the virus transcripts by fluorescence-based quantitative (real-time) RT-PCR; (2) construct high affinity epitope-tagged recombinant antibodies to colocalize latently expressed VZV proteins by in situ immunohistochemistry in sections of human ganglia; and (3) initiate protein function analysis using 2-hybrid systems to identify and map protein-protein interactions. We will begin with VZV IE63, the most prevalent and abundant virus transcript detected to date during latency. An in-depth understanding of VZV gene expression and function in latently infected human ganglia will lead to testable models of latent virus gene regulation (in the developing simian varicella virus model) and to therapies designed to reduce morbidity and mortality associated with reactivation of this highly neurotropic human pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of VZV Reactivation
-
批准号:8476910
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8617880
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8794483
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:9208821
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10343676
-
项目类别:
-
资助金额:$43.82万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:9491548
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10542746
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10097966
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:6746034
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2003
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6565246
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2001
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6410649
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2000
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6302840
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6346297
-
项目类别:
-
资助金额:$24.29万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6112506
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1998
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145433
-
项目类别:
-
资助金额:$13.96万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145435
-
项目类别:
-
资助金额:$14.46万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145434
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:8377749
-
项目类别:
-
资助金额:$33.42万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:7214717
-
项目类别:
-
资助金额:$35.24万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:7578629
-
项目类别:
-
资助金额:$33.24万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
海外基金